Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors

Please use this link to access this publication. Abstract Introduction and Aims Recent years have witnessed increased attention to how cannabis use impacts the use

October 3, 2024

Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey

Abstract People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp

April 16, 2024

Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety

Please use this link to access this publication: https://www.degruyter.com/document/doi/10.1515/revneuro-2023-0078/html Abstract Social anxiety disorder (SAD) is a debilitating disorder, characterized by fear and anxiety in social situations.

November 30, 2023

Subjective and physiological effects after controlled Sativex and oral THC administration

Abstract Sativex is a cannabis-plant extract delivering nearly 1:1 Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) by oromucosal spray. It has been suggested that CBD attenuates THC-induced

November 16, 2023

Subanalyses concerning “Differential impact of Cannabis abuse on neurological disorders

Please use this link to access this publication.  

February 7, 2026

Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus

Please use this link to access this publication. Abstract Use of cannabidiol (CBD), the most abundant non-psychoactive compound found in cannabis (Cannabis sativa), has recently

July 2, 2024

Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s dementia (THC-AD)

Please use this link to access this publication. Abstract Agitation is a common complication of Alzheimer’s dementia (Agit-AD) associated with substantial morbidity, high healthcare service

May 20, 2024

Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia

Abstract Cannabidiol (CBD) exhibits anti-inflammatory and neuroprotective properties and is suggested to be effective in the pre-clinical and clinical treatment of illnesses of the central

April 16, 2024

Studies Investigating the Mechanisms of the Cardioprotective Effects of Cannabidiol

The phytocannabinoid cannabidiol (CBD) has a complex pharmacology which is thought to include, but is not limited to, an ability to act as an inverse

September 19, 2019

Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington’s disease transgenic mice

Loss of cannabinoid receptors (CB1) occurs prior to neurodegeneration in Huntington’s disease (HD). The levels and distribution of CB1 RNA were equivalent in 3-week-old mice